Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma

Charalampos Charalampous; Utkarsh Goel; Prashant Kapoor; Moritz Binder; Francis K. Buadi; Joselle Cook; David Dingli; Angela Dispenzieri; Amie L. Fonder; Morie A. Gertz; Wilson Gonsalves; Suzanne R. Hayman; Miriam A. Hobbs; Yi L. Hwa; Taxiarchis Kourelis; Martha Q. Lacy; Nelson Leung; Yi Lin; Rahma Warsame; Robert A. Kyle; S. Vincent Rajkumar; Shaji K. Kumar

doi:10.1038/s41408-023-00957-w

Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma

Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. KyleS. Vincent Rajkumar, Shaji K. Kumar

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	183
Journal	Blood cancer journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00957-w
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-023-00957-w

Cite this

Charalampous, C., Goel, U., Kapoor, P., Binder, M., Buadi, F. K., Cook, J., Dingli, D., Dispenzieri, A., Fonder, A. L., Gertz, M. A., Gonsalves, W., Hayman, S. R., Hobbs, M. A., Hwa, Y. L., Kourelis, T., Lacy, M. Q., Leung, N., Lin, Y., Warsame, R., ... Kumar, S. K. (2023). Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma. Blood cancer journal, 13(1), Article 183. https://doi.org/10.1038/s41408-023-00957-w

Charalampous, C, Goel, U, Kapoor, P, Binder, M, Buadi, FK, Cook, J, Dingli, D , Dispenzieri, A, Fonder, AL, Gertz, MA , Gonsalves, W, Hayman, SR, Hobbs, MA, Hwa, YL, Kourelis, T , Lacy, MQ, Leung, N, Lin, Y, Warsame, R, Kyle, RA, Rajkumar, SV & Kumar, SK 2023, 'Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma', Blood cancer journal, vol. 13, no. 1, 183. https://doi.org/10.1038/s41408-023-00957-w

@article{d8a36c87d0d54e27be24c66672e3f828,

title = "Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma",

author = "Charalampos Charalampous and Utkarsh Goel and Prashant Kapoor and Moritz Binder and Buadi, {Francis K.} and Joselle Cook and David Dingli and Angela Dispenzieri and Fonder, {Amie L.} and Gertz, {Morie A.} and Wilson Gonsalves and Hayman, {Suzanne R.} and Hobbs, {Miriam A.} and Hwa, {Yi L.} and Taxiarchis Kourelis and Lacy, {Martha Q.} and Nelson Leung and Yi Lin and Rahma Warsame and Kyle, {Robert A.} and Rajkumar, {S. Vincent} and Kumar, {Shaji K.}",

year = "2023",

month = dec,

doi = "10.1038/s41408-023-00957-w",

language = "English (US)",

volume = "13",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma

AU - Charalampous, Charalampos

AU - Goel, Utkarsh

AU - Kapoor, Prashant

AU - Binder, Moritz

AU - Buadi, Francis K.

AU - Cook, Joselle

AU - Dingli, David

AU - Dispenzieri, Angela

AU - Fonder, Amie L.

AU - Gertz, Morie A.

AU - Gonsalves, Wilson

AU - Hayman, Suzanne R.

AU - Hobbs, Miriam A.

AU - Hwa, Yi L.

AU - Kourelis, Taxiarchis

AU - Lacy, Martha Q.

AU - Leung, Nelson

AU - Lin, Yi

AU - Warsame, Rahma

AU - Kyle, Robert A.

AU - Rajkumar, S. Vincent

AU - Kumar, Shaji K.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85179304667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85179304667&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00957-w

DO - 10.1038/s41408-023-00957-w

M3 - Letter

C2 - 38072941

AN - SCOPUS:85179304667

SN - 2044-5385

VL - 13

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 183

ER -

Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this